Researchers from TIFR, ARI, IIT Hyderabad discover Ruthenium-Ferrocene Bimetallic which has the potential to curb primary tumour growth through antiproliferation
Scientists from Mumbai's Tata Institute of Fundamental Research (TIFR), the Agharkar Research Institute (ARI) in Pune, and IIT Hyderabad have discovered an alternative drug molecule indicating high antitumor potential on cancer cells with exceptional ability to reduce unwanted growth of blood vessels (antiangiogenic effect), said one of the scientific team members here on Tuesday.
Scientists from Mumbai's Tata Institute of Fundamental Research (TIFR), the Agharkar Research Institute (ARI) in Pune, and IIT Hyderabad have discovered an alternative drug molecule indicating high antitumor potential on cancer cells with .
Scientists from Mumbai’s Tata Institute of Fundamental Research (TIFR), the Agharkar Research Institute (ARI) in Pune, and IIT Hyderabad have discovered an alternative drug molecule indicating high anti-tumor potential on cancer cells with exceptional ability to reduce unwanted growth of blood vessels (antiangi
Scientists from Mumbai s Tata Institute of Fundamental Research (TIFR), the Agharkar Research Institute (ARI) in Pune, and IIT Hyderabad have discovered an alternative drug molecule indicating high antitumor potential on cancer cells. 🍏 Indian Scientists Discover New Anti-Cancer Agent With Exceptional Results.